EligibleTrials

Clinical trials recruiting for Relapsing-remitting Multiple Sclerosis (RRMS)

6
Recruiting trials
0
US states with sites
6
Countries
17%
Accept healthy volunteers

Phase breakdown

Phase 2 1Phase 3 2Phase 4 1Not applicable 2

Drugs and treatments being studied

InterventionTrials
Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)1
BCD-2811
Dimethyl Fumarate1
Indole-3-propionic acid (IPA)1
Ocrelizumab1
Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons)1
Rocbrutinib1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Relapsing-remitting Multiple Sclerosis (RRMS) often also study these conditions. Each links to its own recruiting-trial list.

Multiple sclerosis 445Secondary-progressive Multiple Sclerosis (SPMS) 4Multiple Sclerosis (MS) 14

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Relapsing-remitting Multiple Sclerosis (RRMS) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.